HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Idoia Martin-Guerrero Selected Research

Mucositis

12/2018Involvement of miRNA polymorphism in mucositis development in childhood acute lymphoblastic leukemia treatment.
1/2018Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Idoia Martin-Guerrero Research Topics

Disease

16Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2022 - 10/2011
9Neoplasms (Cancer)
01/2024 - 07/2009
3Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 05/2015
3Lymphoma (Lymphomas)
02/2013 - 01/2011
2Medulloblastoma
09/2023 - 01/2022
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 07/2019
2Carcinogenesis
01/2022 - 05/2015
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2021 - 08/2013
2Mucositis
12/2018 - 01/2018
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2016 - 07/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Neurodevelopmental Disorders
10/2020
1Diarrhea
12/2018
1Vomiting
12/2018
1Stomatitis
01/2017
1Hypersensitivity (Allergy)
01/2017
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2017
1Peripheral Nervous System Diseases (PNS Diseases)
02/2016
1Drug-Related Side Effects and Adverse Reactions
01/2016
1Non-alcoholic Fatty Liver Disease
03/2015
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2015
1Genetic Translocation (Chromosomal Translocation)
07/2011
1Colorectal Neoplasms (Colorectal Cancer)
01/2011
1Celiac Disease (Celiac Sprue)
07/2009

Drug/Important Bio-Agent (IBA)

12MicroRNAs (MicroRNA)IBA
01/2023 - 06/2014
7Biomarkers (Surrogate Marker)IBA
01/2024 - 07/2019
5Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2015
5Vincristine (Oncovin)FDA LinkGeneric
12/2019 - 01/2016
5Methotrexate (Mexate)FDA LinkGeneric
12/2018 - 10/2011
2Circular RNAIBA
01/2024 - 09/2023
2Long Noncoding RNAIBA
05/2022 - 01/2017
2DNA (Deoxyribonucleic Acid)IBA
07/2019 - 02/2013
2Formaldehyde (Formol)FDA Link
08/2013 - 02/2013
2ParaffinIBA
08/2013 - 02/2013
1CateninsIBA
01/2022
1RNA (Ribonucleic Acid)IBA
03/2021
1Cell-Free Nucleic AcidsIBA
07/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2018
1Daunorubicin (Cerubidine)FDA LinkGeneric
12/2018
1Intergenic DNA (Junk DNA)IBA
10/2018
1AMPA 1 glutamate receptor ionotropicIBA
01/2017
1Asparaginase (Elspar)FDA Link
01/2017
1LipidsIBA
03/2015
1S-Adenosylmethionine (Ademetionine)IBA
03/2015
1VLDL LipoproteinsIBA
03/2015
1Untranslated RNA (Noncoding RNA)IBA
06/2014
1Immunoglobulins (Immunoglobulin)IBA
07/2011
1snRNP Core ProteinsIBA
01/2011
1hydrogen sulfite (bisulfite)IBA
01/2011

Therapy/Procedure

8Therapeutics
12/2019 - 10/2011
1Aftercare (After-Treatment)
01/2019
1Gluten-Free Diet
07/2009